To ascertain if SUMO modification is sufficient to inactivate the inhibitory functions of VHL on tumor cells, we tested whether PIASy-induced SUMO1 modification of VHL resulted in dysregulation of VHL as the cells exit the cell cycle on serum deprivation. The gene discussed is SUMO1; the disease is neoplasm.